Rezolute Inc (RZLT)
4.93
+0.03
(+0.61%)
USD |
NASDAQ |
Oct 04, 16:00
4.95
+0.02
(+0.41%)
After-Hours: 20:00
Rezolute Net Income (Annual): -68.46M for June 30, 2024
Net Income (Annual) Chart
Historical Net Income (Annual) Data
Date | Value |
---|---|
June 30, 2024 | -68.46M |
June 30, 2023 | -51.79M |
June 30, 2022 | -41.06M |
June 30, 2021 | -20.90M |
June 30, 2020 | -20.33M |
June 30, 2019 | -30.45M |
June 30, 2018 | -29.86M |
Date | Value |
---|---|
June 30, 2017 | -20.28M |
June 30, 2016 | -14.94M |
June 30, 2015 | -11.36M |
June 30, 2014 | -9.730M |
June 30, 2013 | -6.728M |
June 30, 2012 | -0.0493M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Annual) Range, Past 5 Years
-68.46M
Minimum
2024
-20.33M
Maximum
2020
-40.51M
Average
-41.06M
Median
2022
Net Income (Annual) Benchmarks
Actinium Pharmaceuticals Inc | -48.82M |
Moderna Inc | -4.714B |
NovaBay Pharmaceuticals Inc | -9.64M |
Palatin Technologies Inc | -29.74M |
iBio Inc | -24.91M |